Table 2.
Biological markers’ evolution before and after surgery on the population of 55 patients.
| Before Surgery | After Surgery | p-Value | Reference Range | |
|---|---|---|---|---|
| Hemoglobin (g/dL) | 12.9 (1.1) | 12.6 (0.9) | 0.215 | 11.5–14.9 |
| Red blood cells (T/L) | 4.51 (0.35) | 4.37 (0.38) | 0.118 | 3.93-5.09 |
| Hematocrit (%) | 39.1 (3.0) | 38.5 (3.1) | 0.447 | 34.4–43.9 |
| MCV (fL) | 85.2 (4.9) | 86.6 (6.0) | <0.001 | 77.9–95.3 |
| Platelets (G/L) | 261.7 (44.7) | 247.6 (57.1) | 0.519 | 185–445 |
| Leucocytes (G/L) | 6.57 (1.76) | 5.64 (1.60) | <0.001 | 4.02–11.42 |
| Folate (μg/L) | 6.0 (4.6) | 8.7 (5.4) | 0.001 | 3–20 |
| Vitamin B12 (ng/L) | 426.6 (162.5) | 394.2 (171.7) (171.69) | 0.004 | 189–883 |
| ASAT (U/L) | 20.7 (6.4) | 18.9 (10.2) | 0.152 | 15–37 |
| ALAT (U/L) | 29.9 (10.5) | 25.5 (14.1) | 0.142 | 14–59 |
| Gamma GT (U/L) | 34.0 (14.1) | 34.2 (38.3) | 0.326 | 5–55 |
| ALP (U/100mL) | 75.0 (19.0) | 69.4 (22.4) | <0.001 | 50–136 |
| Total Bilirubin (µmol/L) | 6.7 (3.3) | 9.7 (4.8) | <0.001 | 0–17 |
| Ferritin (µg/L) | 68.7 (55.9) | 73.8 (68.6) | 0.619 | 8–252 |
| Transferrin (g/L) | 2.55 (0.37) | 2.47 (0.42) | 0.673 | 2.00–3.65 |
| Transferrin Iron Binding Capacity | 62.7 (9.7) | 61.8 (10.5) | 0.746 | 50–80 |
| Transferrin Saturation (%) | 23.5 (8.5) | 31.2 (11.7) | 0.001 | 20–40 |
| Soluble Transferrin Receptor (mg/L) | 1.42 (0.37) | 1.27 (0.35) | <0.001 | 0–1.76 |
| Ceruloplasmin (g/L) | 0.29 (0.05) | 0.28 (0.07) | 0.009 | 0.2–0.4 |
| Haptoglobin (g/L) | 1.18 (0.41) | 0.91 (0.34) | <0.001 | 0.56–2.00 |
(MCV: Mean Corpuscular Volume; ASAT: Asparate Amino-Trasnferase, ALAT: Alanine Amino-Trasnferase, ALP: ALcaline Phosphatase, TIBC: Transferrin Iron Binding Capacity; sTfR: Soluble Transferrin Receptor. Data is expressed as mean and standard deviation, m (SD).